Skip to main content

Grafa News and Videos — Page 1125

Grafa Headlines

Latest

Grafa

Karyopharm bone marrowcancer combination selected for top EHA presentation

Karyopharm Therapeutics (NASDAQ:KPTI) announced that its late-breaking Phase 3 SENTRY clinical trial data has been selected for an oral presentation at the European Hematology Association (EHA) 2026 Congress, placing the treatment among the top six late-breaking abstracts at the event.

Read more: Karyopharm bone marrowcancer combination selected for top EHA presentation
Grafa

INVO Fertility revenue rises 5% as new patent, acquisition anchor growth strategy

INVO Fertility (NASDAQ:IVF) reported a 5% increase in total net revenue for fiscal year 2025, supported by steady expansion across its clinic network and a restructured balance sheet that eliminated several complex legacy equity liabilities.

Read more: INVO Fertility revenue rises 5% as new patent, acquisition anchor growth strategy
Grafa

Cumberland reports positive early-stage data for cancer metastasis drug

Cumberland Pharmaceuticals (NASDAQ:CPIX) and Vanderbilt Health announced that a Phase 2a clinical trial evaluating the investigational drug ifetroban successfully met its primary endpoint, demonstrating safety and tolerability in patients with high-risk solid tumors.

Read more: Cumberland reports positive early-stage data for cancer metastasis drug

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift